Skip to content

Lobaplatin

DRUG15 trials

Sponsors

Harbin Medical University, Guiyang Medical University, Fifth Affiliated Hospital, Sun Yat-Sen University, Sun Yat-sen University, Henan Cancer Hospital

Conditions

Acute Toxic EffectsBreast CancerChemotherapyChemotherapy EffectColorectal CancerEsophageal CancerGastric CancerHead and Neck Squamous Cell Carcinoma

Phase 1

Phase 2

Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer
NCT01483300
Harbin Medical UniversityBreast Cancer
Start: 2011-11-30End: 2014-11-30Target: 80Updated: 2012-01-24
Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN
NCT03117257
Guiyang Medical UniversityLocally Advanced Head and Neck Squamous Cell Carcinoma
Start: 2016-08-19End: 2021-08-20Target: 144Updated: 2017-04-17
A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.
NCT03210389
Sun Yat-sen UniversityRecurrent Nasopharyngeal Carcinoma
Start: 2017-07-31End: 2021-12-31Target: 60Updated: 2017-07-06
A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC
NCT03700359
The First Affiliated Hospital of Guangzhou Medical UniversitySmall Cell Lung Carcinoma
Start: 2019-03-01End: 2021-11-29Target: 60Updated: 2019-11-29
Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
NCT04808466
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyChemotherapy Effect, Gastric Cancer, Metastasis +2
Start: 2021-09-18End: 2025-09-01Target: 231Updated: 2022-02-21
Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy
Not yet recruitingNCT04845490
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyChemotherapy Effect, Colorectal Cancer, Metastasis +2
Start: 2022-09-01End: 2026-09-01Target: 201Updated: 2022-02-21
Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
NCT05546255
Chinese Academy of Medical SciencesTriple Negative Breast Cancer
Start: 2020-06-01End: 2023-12-31Target: 40Updated: 2022-09-19
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
NCT06170697
Cancer Institute and Hospital, Chinese Academy of Medical SciencesHead and Neck Squamous Cell Carcinoma
Start: 2023-03-01End: 2025-07-31Target: 46Updated: 2023-12-20
Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
RecruitingNCT06714383
Peking University People's HospitalOsteosarcoma
Start: 2024-11-13End: 2025-11-30Target: 50Updated: 2024-12-03

Phase 3

Phase 4

Related Papers